Advances in Insulin Therapy: A Review of New Insulin Glargine 300 Units/mL in the Management of Diabetes

In Brief New insulin glargine 300 units/mL (Gla-300) is a formulation of insulin glargine that has a more constant pharmacokinetic profile with a prolonged duration of action. The EDITION clinical trial program showed that the use of Gla-300 leads to glycemic control comparable to that of insulin gl...

Descripción completa

Detalles Bibliográficos
Autor principal: White, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2016
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833483/
https://www.ncbi.nlm.nih.gov/pubmed/27092018
http://dx.doi.org/10.2337/diaclin.34.2.86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833483/
https://www.ncbi.nlm.nih.gov/pubmed/27092018
http://dx.doi.org/10.2337/diaclin.34.2.86

Ejemplares similares